Hormone replacement therapy usage: A 10 year experience of a solo practitioner

Maturitas

Volumn 29, Issue 1, 1998, Pages 67-73

  Halbert, David R ^a   Lloyd, Tom ^a   Rollings, Nan ^a   Kowalski, Wendy ^a   Mauger, Elizabeth ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Gynecology; Obstetrics; Postmenopausal; Reproductive histories

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; EDUCATION; EXERCISE; FEMALE; GYNECOLOGY; HEALTH EDUCATION; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE AND RELATED PHENOMENA; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; OBSTETRICS; POSTMENOPAUSE;

COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MENOPAUSE; MIDDLE AGED; PATIENT COMPLIANCE; PENNSYLVANIA; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 0032550701     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(97)00077-7     Document Type: Article

References (32)

1. Session DR, Kelly AC, Jewelewicz R. Current concepts in estrogen replacement therapy in the menopause. Fertil Steril. 59:1993;277-284.
2. Holinka CF. Aspects of hormone replacement therapy. Ann New York Acad Sci. 734:1994;271-284.
3. Barrett-Connor E. Risks and benefits of replacement estrogen. Annu Rev Med. 43:1992;239-251.
4. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann Int Med. 117:1992;1016-1037.
5. Udoff L, Langenberg P, Adashi EY. Combined continuous hormone replacement therapy: a critical review. Obstet Gynecol. 86:1995;306-316.
6. Hammond CB. Menopause and hormone replacement therapy: an overview. Obstet Gynecol. 87:1996;2S-15.
7. Barrett-Connor E. Acceptability and continuation of hormone replacement therapy. Proceedings of the Novo Nordisk International Symposium. Copehagen (Denmark), 1994:1-11.
8. Stumpf PG, Trolice MP. Compliance problems with hormone replacement therapy. Obstet Gynecol Clin North Am. 21:1994;219-228.
9. Hammond CB Hammond and Women's concerns with hormone replacement therapy-compliance issues. Women's concerns with hormone replacement therapy-compliance issues. Fertil Steril. 62:1994;S157-S160.
10. Ravnikar V. Compliance with hormone therapy. Am J Obstet Gynecol. 156:1987;1332-1334.
11. Wren BG, Brown L. Compliance with hormone replacement therapy. Maturitas. 13:1991;17-21.
12. Coope J, Marsh J. Can we improve compliance with long-term HRT? Maturitas. 15:1992;151-158.
13. Hahn RG. Compliance considerations with estrogen replacement: withdrawal bleeding and other factors. Am J Obstet Gynecol. 161:1989;1854-1858.
14. Boulet MJ, Oddeus BJ. Informing women about the menopause and HRT: Media or physicians? 7th International Congress on the Menopause. Stockholm (Sweden), 1993.
15. Draper J, Roland M. Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis. Br Med J. 300:1990;786-788.
16. Lancaster T, Surman G, Lawrence M, Mant D, Vessey M, Thorogood M, Yudkin P, Daly E. Hormone replacement therapy: characteristics of users and non-users in a British general practice identified through computerized prescribing records. J Epidemiol Community Health. 49:1995;389-394.
17. Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy: a survey of women's knowledge and attitudes. Arch Int Med. 149:1989;133-136.
18. Nachtigall LE Nachtigall and Enhancing patient compliance with hormone replacement therapy at menopause. Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol. 75:1990;S77-S80.
19. Ryan PJ, Harrison R, Blake GM, Fogelman L. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynecol. 99:1992;325-328.
20. Doren M, Reuther G, Minne HW, Schneider HPG. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmeno-pausal women. Am J Obstet Gynecol. 173:1995;1446-1451.
21. Berman RS, Epstein RS, Lydick EG. Compliance of women taking estrogen replacement therapy. J Women's Health. 5:1996;213-220.
22. Woolson RF. Statistical Methods for the Analysis of Biomedical Data. New York: Wiley, 1987.
23. Agresti A. Categorical Data Analysis. New York: Wiley, 1990.
24. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: Wiley, 1980.
25. th ed. In: Wilson JD, Foster DW, editors. Philadelphia: Saunders, 1992:1337.
26. Sbarbaro JA The patient-physician relationship. Compliance revisited. Ann Allergy. 64:1990;325-331.
27. Rozenberg S, Vandromme J, Kroll M, Pastijn A, Liekens F. Compliance to hormone replacement therapy. Int J Fertil. 40:1995;23-32.
28. Griffith S. A review of the factors associated with patient compliance and the taking of prescribed medicines. Br J Gen Pract. 40:1990;114-116.
29. Stampfer MJ, Colditz GA, Wuillett WC, Mauson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten year follow-up from the Nurses' Health Study. New Engl J Med. 325:1991;756-762.
30. Ravnikar V. Compliance with hormone replacement therapy: are women receiving the full impact of hormone replacement therapy preventive health benefits? Women's Health Issues. 2:1992;75-82.
31. Isaacs AJ, Britton AR, McPherson K. Utilization of hormome replacement therapy by women doctors. Br Med J 1995; 311:1399-401.
32. Lafferty FW, Fiske ME. Postmenopausalestrogen replacement: A long-term cohort study. Am J Med 1994;97:66-77.